|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-6-12
|
|
pubmed:abstractText |
Prostate specific antigen is used for prostate cancer screening but its specificity is limited. Specificity might be increased by considering genotype associated prostate specific antigen levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-3792
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
182
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-4; discussion 105
|
|
pubmed:meshHeading |
pubmed-meshheading:19450841-Adult,
pubmed-meshheading:19450841-Age Factors,
pubmed-meshheading:19450841-Aged,
pubmed-meshheading:19450841-Aging,
pubmed-meshheading:19450841-Biopsy, Needle,
pubmed-meshheading:19450841-Chromosomes, Human, Pair 10,
pubmed-meshheading:19450841-Chromosomes, Human, Pair 19,
pubmed-meshheading:19450841-Cohort Studies,
pubmed-meshheading:19450841-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19450841-Genetic Predisposition to Disease,
pubmed-meshheading:19450841-Humans,
pubmed-meshheading:19450841-Immunohistochemistry,
pubmed-meshheading:19450841-Incidence,
pubmed-meshheading:19450841-Longitudinal Studies,
pubmed-meshheading:19450841-Male,
pubmed-meshheading:19450841-Middle Aged,
pubmed-meshheading:19450841-Neoplasm Staging,
pubmed-meshheading:19450841-Polymorphism, Single Nucleotide,
pubmed-meshheading:19450841-Probability,
pubmed-meshheading:19450841-Prognosis,
pubmed-meshheading:19450841-Proportional Hazards Models,
pubmed-meshheading:19450841-Prostate-Specific Antigen,
pubmed-meshheading:19450841-Prostatic Neoplasms,
pubmed-meshheading:19450841-Risk Assessment,
pubmed-meshheading:19450841-Sensitivity and Specificity,
pubmed-meshheading:19450841-Survival Analysis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.
|
|
pubmed:affiliation |
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. stacyloeb@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|
